Springer Medicine

What you need to know about closed-loop systems for the management of diabetes, from real-world data to expanding indications, access, implementation, and limitations.

An ultrasound-first strategy can diagnose giant cell arteritis rapidly and effectively, and avoid the need for temporal artery biopsy in around two-fifths of cases.

Overlapping clinical phenotypes make diagnosis challenging in patients with mild cognitive impairment. What clinical and biological features can help characterise dementia with Lewy bodies versus Alzheimer's disease?

Switching to clopidogrel monotherapy rather than continuing DAPT after PCI for acute coronary syndrome can reduce the risk of subsequent bleeding.

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.